Cancer Progress

We look forward to seeing you at the 26th Annual Cancer Progress Conference on March17-18 at the Grand Hyatt
New York in New York City!


Cancer Progress

Since 1985, Cancer Progress is the only oncology conference that invites a discussion of scientific progress within the context of development, regulatory, clinical, commercial and investment perspectives in two days of interactive dialogue. Pivotal topics, frank discussions, vigorous debate, lively audience participation and generous networking throughout the meeting during breaks, luncheons, reception and dinner combine to make this a highly impactful conference.

Our 26th Annual Meeting on March 17-18, 2015 will  provide an unsurpassed learning experience for participants in quality of information, coverage of issues, and value of professional contacts. The quality of the speaking faculty is a major contributor to the popularity and value of this conference. Confirmed speakers as of July 4, 2014 are:

  • Peter C. Adamson, MD, The Children’s Hospital of Philadelphia
  • Rafael Amado, MD, GlaxoSmithKline
  • Peter Bach, MD,  Memorial Sloan-Kettering Cancer Center
  • Jeff Bockman, PhD, VP, Defined Health
  • Renier J. Brentjens, MD, PhD, Memorial Sloan Kettering Cancer Center
  • Robert Cohen, MD, Calico Life Sciences
  • Heather Cooper-Ortner, Dr. Susan Love Research Foundation
  • Thomas J. Farrell, CEO, Bellicum Pharmaceuticals
  • Carlos Rodriguez-Galindo, MD, Harvard Medical School
  • Richard Brian Gaynor, MD, Eli Lilly and Company
  • William Grossman, MD, PhD, AbbVie
  • Axel Hoos, MD, PhD,  GlaxoSmithKline
  • Clifford A. Hudis, MD, Memorial Sloan Kettering Cancer Center, 2013-2014 President, ASCO
  • Amy Krie, MD, Avera Cancer Institute
  • Ross Levine, MD, Memorial Sloan Kettering Cancer Center
  • Brian Leyland-Jones, MD, Avera Cancer Institute
  • Hy Levitsky, MD, Roche Pharmaceuticals
  • Patricia LoRusso, D.O.,  Wayne State University
  • Susan Love, MD, Dr. Susan Love Research  Foundation
  • Franziska Michor, PhD,  Harvard School of Public Health
  • Ronnie Morris, MD, Champions Oncology
  • Lee Newcomer, MD, MHA, United Healthcare
  • Larry Norton, MD, Memorial Sloan Kettering Cancer Center
  • Mike Rice, MS, MBA, Senior Consultant, Defined Health
  • Neal Rosen, MD, PhD, Memorial Sloan Kettering Cancer Center
  • Eric Rowinsky, MD, Stemline Therapeutics
  • Rob Ruijtenbeek, PamGene BV
  • Prof. Dolores J. Schendel, PhD, Medigene
  • Jeffrey Settleman, PhD, Genetech
  • Angela Shen, MD, MBA, Novartis Pharmaceuticals Corp.
  • Mark J. Simon, Torreya Partners LLC
  • David Solit, MD, Memorial Sloan Kettering Cancer Center
  • Chris H. Takimoto, MD, PhD, Janssen Research & Development
  • Marc Theoret, MD, FDA
  • Jedd Wolchok, MD, PhD, Memorial Sloan-Kettering Cancer Center
  • Cassian Yee MD, MD Anderson Cancer Center

We look forward to seeing you at the 26th Annual Cancer Progress Conference on March17-18 at the Grand Hyatt New York in New York City!